Richard Lipscombe — Email, Phone & Partners

Overview

Richard Lipscombe is a seasoned angel investor specializing in healthcare startups, with a focus on biotechnology and medical diagnostics. He has over 30 years of international experience in Australia, the USA, and the UK, encompassing both scientific research and business management. His expertise spans chemistry, immunology, mass spectrometry, peptide synthesis, high-performance computing, and robotics. He holds a chemistry degree from Oxford University and a PhD in immunology from London University. Prior to his entrepreneurial ventures, he worked as a post-doctoral scientist in molecular immunology at the Telethon Kids Institute in Australia. In 2001, Dr. Lipscombe co-founded Proteomics International Laboratories Ltd (ASX: PIQ), a medical technology company specializing in predictive diagnostics and bio-analytical services. As Managing Director, he led the company from its foundation through its listing on the Australian Securities Exchange in 2015. Under his leadership, Proteomics International has developed a versatile platform technology for discovering diagnostic tests, focusing on the sensitive, early detection of diseases. The company has been at the forefront of precision diagnostics and personalized medicine, utilizing proteomics techniques to improve disease treatment. Dr. Lipscombe has been actively involved in investor presentations and forums, showcasing the company's advancements and innovations. He has also been a key figure in the company's strategic direction and growth, contributing to its recognition as a leader in precision diagnostics. In September 2025, he announced his intention to retire in February 2026, coinciding with his 25th anniversary as Founder and Managing Director of Proteomics International. This planned transition reflects his commitment to ensuring the company's continued success and leadership in the field of precision medicine.

Investment Focus

Innovative healthcare solutions
Scalable business models
Experienced management teams
Strong intellectual property portfolios
Clear regulatory pathways
Potential for significant market impact
Alignment with personal investment philosophy

Portfolio Companies

Proteomics International Laboratories Ltd

Reach Richard Lipscombe directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about Richard Lipscombe

What sectors does Richard Lipscombe invest in?

Richard Lipscombe invests in Healthcare, Pharmaceuticals, Medical Devices, Diagnostics, Robotics and Biotechnology, and is based in Western Australia, Australia. Richard Lipscombe is listed as a angel investor in the ConnectSafely investor database.